Clinical Trial Update: Trial of Liposomal Bupivacaine for TKA [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating liposomal bupivacaine for postoperative pain after total knee arthroplasty has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Knee Replacement
• Post-operative Pain
• Total Knee Arthroplasty

Drugs mentioned

• Liposomal bupivacaine (bupivacaine liposome injectable suspension)

Snippet

Sponsor: Northern Light Mercy Hospital | Conditions: Knee Replacement, Total Knee Arthroplasty | Phase 4 | Status: COMPLETED